Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts.
Market Cap | 27.699 Million | Shares Outstanding | 7.486 Million | Avg 30-day Volume | 20.03 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.31 |
Price to Revenue | 1.1493 | Debt to Equity | 0.0 | EBITDA | -12.865 Million |
Price to Book Value | 2.2623 | Operating Margin | -96.00840000000001 | Enterprise Value | 10.787 Million |
Current Ratio | 3.07 | EPS Growth | 0.065 | Quick Ratio | 2.505 |
1 Yr BETA | 0.3461 | 52-week High/Low | 7.35 / 0.62 | Profit Margin | -95.8943 |
Operating Cash Flow Growth | 26.025 | Altman Z-Score | -29.2655 | Free Cash Flow to Firm | -6.556 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
31,834 | 2021-11-01 | 1 | |
|
29,845 | 2021-11-01 | 1 | |
HAYWARD JAMES A CHAIRMAN, CEO AND PRESIDENT |
|
219,167 | 2021-11-01 | 1 |
|
30,094 | 2021-11-01 | 1 | |
MURRAH JUDITH CIO AND COO |
|
52,127 | 2021-11-01 | 1 |
|
31,586 | 2021-11-01 | 1 | |
|
30,840 | 2021-11-01 | 1 | |
JANTZEN BETH CHIEF FINANCIAL OFFICER |
|
45,129 | 2021-11-01 | 1 |
|
29,845 | 2021-11-01 | 1 | |
|
29,845 | 2021-11-01 | 1 | |
SHORROCK CLAY CHIEF LEGAL OFFICER |
|
45,129 | 2021-11-01 | 1 |
|
No longer subject to file | 2020-06-26 | 0 | |
|
0 | 2019-05-17 | 0 | |
LIANG MING-HWA BENJAMIN SECRETARY AND CSO |
|
0 | 2016-12-20 | 0 |
GRAY KAROL CHIEF FINANCIAL OFFICER |
|
0 | 2014-12-22 | 0 |
SHAMASH YACOV |
|
0 | 2006-03-17 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
APPLIED DNA SCIENCES INC APDN | 2022-08-15 19:45:04 UTC | -201.2809 | 203.6009 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 19:15:04 UTC | -201.2809 | 203.6009 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 18:45:04 UTC | -204.6528 | 206.9728 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 18:15:04 UTC | -204.6528 | 206.9728 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 17:45:04 UTC | -204.6528 | 206.9728 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 17:15:03 UTC | -204.6528 | 206.9728 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 16:45:04 UTC | -204.0721 | 206.3921 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 16:15:04 UTC | -204.0721 | 206.3921 | 50000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 15:45:04 UTC | -204.0721 | 206.3921 | 50000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 15:15:04 UTC | -204.0721 | 206.3921 | 40000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 14:45:04 UTC | -204.0721 | 206.3921 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 14:15:03 UTC | -204.0721 | 206.3921 | 45000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 13:45:04 UTC | -236.5463 | 238.8663 | 4000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 13:15:04 UTC | -236.5463 | 238.8663 | 5000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-15 12:45:04 UTC | -236.5463 | 238.8663 | 35000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-12 22:15:03 UTC | -236.5463 | 238.8663 | 7000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-12 21:45:04 UTC | -240.035 | 242.355 | 7000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-12 21:15:04 UTC | -240.035 | 242.355 | 7000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-12 15:45:04 UTC | -311.0136 | 313.3336 | 30000 |
APPLIED DNA SCIENCES INC APDN | 2022-08-12 15:15:05 UTC | -311.0136 | 313.3336 | 40000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|